Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal

This study has been completed.
Information provided by (Responsible Party):
AstraZeneca Identifier:
First received: October 16, 2005
Last updated: August 29, 2011
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)